D E Duggan

4.3k total citations
76 papers, 3.6k citations indexed

About

D E Duggan is a scholar working on Pharmacology, Molecular Biology and Oncology. According to data from OpenAlex, D E Duggan has authored 76 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pharmacology, 27 papers in Molecular Biology and 22 papers in Oncology. Recurrent topics in D E Duggan's work include Pharmacogenetics and Drug Metabolism (26 papers), Drug Transport and Resistance Mechanisms (19 papers) and Inflammatory mediators and NSAID effects (12 papers). D E Duggan is often cited by papers focused on Pharmacogenetics and Drug Metabolism (26 papers), Drug Transport and Resistance Mechanisms (19 papers) and Inflammatory mediators and NSAID effects (12 papers). D E Duggan collaborates with scholars based in United States, France and Japan. D E Duggan's co-authors include K.C. Kwan, R.M. Noll, Sidney Udenfriend, S. Vickers, K F Hooke, Jiunn H. Lin, F. Gilbert McMahon, C A Duncan, David M. Cocchetto and Bernard B. Brodie and has published in prestigious journals such as Nature, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

D E Duggan

75 papers receiving 3.3k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
D E Duggan 1.2k 873 741 713 425 76 3.6k
Terry V. Zenser 1.4k 1.2× 704 0.8× 418 0.6× 828 1.2× 272 0.6× 172 3.8k
Michinao Mizugaki 2.5k 2.0× 617 0.7× 447 0.6× 1.0k 1.4× 198 0.5× 251 5.1k
Gerard J. Mulder 2.5k 2.0× 412 0.5× 1.0k 1.4× 1.4k 1.9× 258 0.6× 179 5.1k
Urs A. Boelsterli 1.7k 1.4× 817 0.9× 1.1k 1.5× 2.4k 3.3× 312 0.7× 110 5.3k
David Zakim 2.4k 1.9× 322 0.4× 469 0.6× 570 0.8× 505 1.2× 150 4.7k
Atsushi Kurihara 686 0.6× 766 0.9× 559 0.8× 766 1.1× 650 1.5× 88 3.7k
Heike Gutmann 1.3k 1.1× 401 0.5× 1.9k 2.5× 605 0.8× 505 1.2× 121 4.9k
Jordan L. Holtzman 1.1k 0.9× 239 0.3× 461 0.6× 1.0k 1.4× 173 0.4× 145 3.5k
J. Noordhoek 931 0.8× 284 0.3× 667 0.9× 960 1.3× 162 0.4× 149 3.1k
Gopal Krishna 1.5k 1.2× 258 0.3× 400 0.5× 932 1.3× 252 0.6× 65 3.7k

Countries citing papers authored by D E Duggan

Since Specialization
Citations

This map shows the geographic impact of D E Duggan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D E Duggan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D E Duggan more than expected).

Fields of papers citing papers by D E Duggan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D E Duggan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D E Duggan. The network helps show where D E Duggan may publish in the future.

Co-authorship network of co-authors of D E Duggan

This figure shows the co-authorship network connecting the top 25 collaborators of D E Duggan. A scholar is included among the top collaborators of D E Duggan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D E Duggan. D E Duggan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Halpin, Rita A., E H Ulm, A. E. Till, et al.. (1993). Biotransformation of lovastatin. V. Species differences in in vivo metabolite profiles of mouse, rat, dog, and human.. Drug Metabolism and Disposition. 21(6). 1003–1011. 47 indexed citations
2.
Lin, Jiunn H., et al.. (1992). Effects of dose, sex, and age on the disposition of alendronate, a potent antiosteolytic bisphosphonate, in rats.. Drug Metabolism and Disposition. 20(4). 473–478. 87 indexed citations
3.
Lin, Jiunn H., et al.. (1990). Dose-dependent pharmacokinetics of MK-417, a potent carbonic anhydrase inhibitor, in rabbits following single and multiple doses.. Drug Metabolism and Disposition. 18(6). 836–841. 4 indexed citations
4.
Duggan, D E & S. Vickers. (1990). Physiological Disposition of Hmg-Coa-Reductase Inhibitors. Drug Metabolism Reviews. 22(4). 333–362. 62 indexed citations
5.
Vickers, S., C A Duncan, Kamlesh P. Vyas, et al.. (1990). In vitro and in vivo biotransformation of simvastatin, an inhibitor of HMG CoA reductase.. Drug Metabolism and Disposition. 18(4). 476–483. 136 indexed citations
6.
Duggan, D E, W.F. Bayne, Rita A. Halpin, et al.. (1989). The physiological disposition of lovastatin.. Drug Metabolism and Disposition. 17(2). 166–173. 102 indexed citations
7.
Vyas, Kamlesh P., P H Kari, S. Vickers, et al.. (1988). Metabolism of simvastatin s by rat and mouse liver microsomes. The FASEB Journal. 2(5). 4444. 1 indexed citations
8.
Lin, J H, et al.. (1987). Differential effects of phenobarbital on ester and ether glucuronidation of diflunisal in rats.. Journal of Pharmacology and Experimental Therapeutics. 242(3). 1013–1018. 11 indexed citations
9.
Lin, J H, David M. Cocchetto, K. C. Yeh, & D E Duggan. (1986). Comparative effects of H2-receptor antagonists on drug interaction in rats.. Drug Metabolism and Disposition. 14(6). 649–653. 10 indexed citations
10.
Lin, J H, E H Ulm, & D E Duggan. (1986). Possible mechanisms for reduced plasma clearance of diflunisal in rat experimental renal failure.. Journal of Pharmacology and Experimental Therapeutics. 238(3). 978–984. 13 indexed citations
11.
12.
Yeh, K. C., et al.. (1985). Effect of uremia and anephric state on the pharmacokinetics of sulindac and its metabolites in rats. II. Differential effects on the biliary excretion.. Drug Metabolism and Disposition. 13(5). 608–613. 3 indexed citations
13.
Duggan, D E, K F Hooke, & Stephen S. Hwang. (1980). Kinetics of the tissue distributions of sulindac and metabolites. Relevance to sites and rates of bioactivation.. Drug Metabolism and Disposition. 8(4). 241–246. 63 indexed citations
14.
Duggan, D E, et al.. (1977). Identification of the biologically active form of sulindac.. Journal of Pharmacology and Experimental Therapeutics. 201(1). 8–13. 115 indexed citations
15.
Duggan, D E, J. J. Baldwin, Byron H. Arison, & Ryan E. Rhodes. (1974). N-GLUCOSIDE FORMATION AS A DETOXIFICATION MECHANISM IN MAMMALS. Journal of Pharmacology and Experimental Therapeutics. 190(3). 563–569. 30 indexed citations
16.
Duggan, D E, et al.. (1972). THE METABOLISM OF INDOMETHACIN IN MAN. Journal of Pharmacology and Experimental Therapeutics. 181(3). 563–575. 142 indexed citations
17.
Duggan, D E, et al.. (1968). Purine Metabolism in the Chick Embryo; Effects of Uricogenesis and Xanthine Oxidase Inhibition. Molecular Pharmacology. 4(1). 53–60. 4 indexed citations
18.
Duggan, D E. (1966). THE ACCUMULATION OF CHLOROTHIAZIDE AND RELATED SALURETIC AGENTS BY ISOLATED RENAL TUBULES. Journal of Pharmacology and Experimental Therapeutics. 152(1). 122–129. 9 indexed citations
19.
Duggan, D E & Elwood Titus. (1960). THE METABOLISM OF 6-CHLOROPURINE-8-C14 IN THE RAT. Journal of Pharmacology and Experimental Therapeutics. 130(4). 375–382. 11 indexed citations
20.
Udenfriend, Sidney, et al.. (1957). A SPECTROPHOTOFLUOROMETRIC STUDY OF ORGANIC COMPOUNDS OF PHARMACOLOGICAL INTEREST. Journal of Pharmacology and Experimental Therapeutics. 120(1). 26–32. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Terry V. Zenser Breakdown of academic impact, for papers by Michinao Mizugaki Breakdown of academic impact, for papers by Gerard J. Mulder Breakdown of academic impact, for papers by Urs A. Boelsterli Breakdown of academic impact, for papers by David Zakim Breakdown of academic impact, for papers by Atsushi Kurihara Breakdown of academic impact, for papers by Heike Gutmann Breakdown of academic impact, for papers by Jordan L. Holtzman Breakdown of academic impact, for papers by J. Noordhoek Breakdown of academic impact, for papers by Gopal Krishna
Rankless by CCL
2026